Concepedia

Elena Rinaldi

ER

8

Publications

585

Citations

8

H-Index

2017

Active since

Affiliations

Fondazione IRCCS Istituto Neurologico Carlo Besta(Current)

UCB Pharma (United States)

Centre Hospitalier Universitaire de Nice

National Hospital Organization Hanamaki Hospital

UCB Pharma (United Kingdom)

Elena Rinaldi is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, clinical trials, and neuroimmunology.

ORCID

Top concepts

Publications per year

2017–2024

8

Publications

8

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

, , +3

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

, , +1

Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats

Alessandra Consonni, Chiara Cordiglieri, Elena Rinaldi et al. · Oncotarget · 2018 · 42 citations · Full text

Efgartigimod in generalized myasthenia gravis: A real‐life experience at a national reference center

Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli et al. · European Journal of Neurology · 2024 · 40 citations · Full text

Therapeutic Effect of Bifidobacterium Administration on Experimental Autoimmune Myasthenia Gravis in Lewis Rats

Elena Rinaldi, Alessandra Consonni, Chiara Cordiglieri et al. · Frontiers in Immunology · 2019 · 32 citations · Full text

Rows per page

1–5 of 8